early movers 5-14
ARTX +22% RGDX +15%
#PREMARKET GAINERS
SNPMarketScope ViewsNews 2014-05-14 08:08:04.000 ARTX AROTECH CORPORATION Acquire Media BENZINGA'S TOP #PREMARKET GAINERS Arotech (NASDAQ: ARTX) shares climbed 22.09% to $4.09 in the pre-market trading session after the company reported upbeat Q1 earnings. Arotech reported its quarterly earnings of $0.05 per share on revenue of $22.40 million. Isis Pharmaceuticals (NASDAQ: ISIS) soared 5.62% to $26.50 in the pre-market trading after the company reported positive Phase 2 data on ISIS-GCGR Rx in HbA1c in patients with type 2 diabetes. Canadian Solar (NASDAQ: CSIQ) shares jumped 2.56% to $28 in pre-market trading as Coca the company announced a partnership with IKEA Australia to build 3.6MW solar systems. MannKind (NASDAQ: MNKD) shares gained 2.43% to $6.74 in pre-market trading after Piper Jaffray upgraded the stock from Underweight to Neutral.. 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Acquire Media |US;ARTX |3260 |US |48398.
Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy selection, today announced execution of a commercial agreement with DxM Diagnostico Molecular ("DIFRA"), a leading distributor for cancer testing in Mexico, to offer the ResponseDX testing services to patients throughout Mexico.